Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

The human secretome.

Uhlén M, Karlsson MJ, Hober A, Svensson AS, Scheffel J, Kotol D, Zhong W, Tebani A, Strandberg L, Edfors F, Sjöstedt E, Mulder J, Mardinoglu A, Berling A, Ekblad S, Dannemeyer M, Kanje S, Rockberg J, Lundqvist M, Malm M, Volk AL, Nilsson P, Månberg A, Dodig-Crnkovic T, Pin E, Zwahlen M, Oksvold P, von Feilitzen K, Häussler RS, Hong MG, Lindskog C, Ponten F, Katona B, Vuu J, Lindström E, Nielsen J, Robinson J, Ayoglu B, Mahdessian D, Sullivan D, Thul P, Danielsson F, Stadler C, Lundberg E, Bergström G, Gummesson A, Voldborg BG, Tegel H, Hober S, Forsström B, Schwenk JM, Fagerberg L, Sivertsson Å.

Sci Signal. 2019 Nov 26;12(609). pii: eaaz0274. doi: 10.1126/scisignal.aaz0274.

PMID:
31772123
2.
3.

Hope in Hospitalized Patients with Terminal Cancer.

Baczewska B, Block B, Kropornicka B, Niedzielski A, Malm M, Zwolak A, Makara-Studzińska M.

Int J Environ Res Public Health. 2019 Oct 12;16(20). pii: E3867. doi: 10.3390/ijerph16203867.

4.

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana.

Malm M, Diessner A, Tamminen K, Liebscher M, Vesikari T, Blazevic V.

Pharmaceutics. 2019 May 11;11(5). pii: E229. doi: 10.3390/pharmaceutics11050229.

5.

Development of T cell immunity to norovirus and rotavirus in children under five years of age.

Malm M, Hyöty H, Knip M, Vesikari T, Blazevic V.

Sci Rep. 2019 Mar 1;9(1):3199. doi: 10.1038/s41598-019-39840-9.

6.

Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant.

Tamminen K, Malm M, Vesikari T, Blazevic V.

Viruses. 2019 Jan 22;11(2). pii: E91. doi: 10.3390/v11020091.

7.

Identification of a First Human Norovirus CD8+ T Cell Epitope Restricted to HLA-A*0201 Allele.

Malm M, Vesikari T, Blazevic V.

Front Immunol. 2018 Nov 27;9:2782. doi: 10.3389/fimmu.2018.02782. eCollection 2018.

8.

Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.

Malm M, Tamminen K, Vesikari T, Blazevic V.

Viral Immunol. 2018 Nov 15. doi: 10.1089/vim.2018.0115. [Epub ahead of print]

PMID:
30431404
9.

Early Implant Failures in Edentulous Patients: A Multivariable Regression Analysis of 4615 Consecutively Treated Jaws. A Retrospective Study.

Malm MO, Jemt T, Stenport V.

J Prosthodont. 2018 Dec;27(9):803-812. doi: 10.1111/jopr.12985. Epub 2018 Oct 29.

PMID:
30307086
10.

Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens.

Tamminen K, Malm M, Vesikari T, Blazevic V.

Clin Immunol. 2018 Dec;197:110-117. doi: 10.1016/j.clim.2018.09.009. Epub 2018 Sep 19.

PMID:
30244152
11.

Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential.

Heinimäki S, Malm M, Vesikari T, Blazevic V.

Antiviral Res. 2018 Sep;157:1-8. doi: 10.1016/j.antiviral.2018.06.012. Epub 2018 Jun 21.

PMID:
29935205
12.

Mechanical and spectroscopic characterization of crosslinked zein films cast from solutions of acetic acid leading to a new mechanism for the crosslinking of oleic acid plasticized zein films.

Turasan H, Barber EA, Malm M, Kokini JL.

Food Res Int. 2018 Jun;108:357-367. doi: 10.1016/j.foodres.2018.03.063. Epub 2018 Mar 22.

PMID:
29735068
13.
14.
15.

Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes.

Malm M, Tamminen K, Heinimäki S, Vesikari T, Blazevic V.

Vaccine. 2018 Jan 25;36(4):484-490. doi: 10.1016/j.vaccine.2017.12.009. Epub 2017 Dec 13.

16.

Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens.

Heinimäki S, Tamminen K, Malm M, Vesikari T, Blazevic V.

Virology. 2017 Nov;511:114-122. doi: 10.1016/j.virol.2017.08.023. Epub 2017 Aug 24.

17.

Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.

Malm M, Heinimäki S, Vesikari T, Blazevic V.

Clin Exp Immunol. 2017 Sep;189(3):331-341. doi: 10.1111/cei.12977. Epub 2017 May 16.

18.

Norovirus-Specific Memory T Cell Responses in Adult Human Donors.

Malm M, Tamminen K, Vesikari T, Blazevic V.

Front Microbiol. 2016 Oct 3;7:1570. eCollection 2016.

19.

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles.

Malm M, Tamminen K, Lappalainen S, Vesikari T, Blazevic V.

J Immunol Res. 2016;2016:9171632. Epub 2016 Sep 4.

20.

Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein.

Malm M, Tamminen K, Vesikari T, Blazevic V.

Mol Immunol. 2016 Oct;78:27-37. doi: 10.1016/j.molimm.2016.08.009. Epub 2016 Aug 29.

PMID:
27573255
21.

Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds.

Malm M, Frejd FY, Ståhl S, Löfblom J.

MAbs. 2016 Oct;8(7):1195-1209. Epub 2016 Aug 17. Review.

22.

Rotavirus vaccination and infection induce VP6-specific IgA responses.

Lappalainen S, Blazevic V, Malm M, Vesikari T.

J Med Virol. 2017 Feb;89(2):239-245. doi: 10.1002/jmv.24636. Epub 2016 Aug 6.

PMID:
27431308
23.

Prenatal attachment and its association with foetal movement during pregnancy - A population based survey.

Malm MC, Hildingsson I, Rubertsson C, Rådestad I, Lindgren H.

Women Birth. 2016 Dec;29(6):482-486. doi: 10.1016/j.wombi.2016.04.005. Epub 2016 Apr 29.

PMID:
27140328
24.

Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding.

Tamminen K, Malm M, Vesikari T, Blazevic V.

Viral Immunol. 2016 Jun;29(5):315-9. doi: 10.1089/vim.2015.0141. Epub 2016 May 2.

PMID:
27135874
25.

Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.

Malm M, Tamminen K, Blazevic V.

Methods Mol Biol. 2016;1403:259-68. doi: 10.1007/978-1-4939-3387-7_13.

PMID:
27076135
26.

Development and maturation of norovirus antibodies in childhood.

Blazevic V, Malm M, Honkanen H, Knip M, Hyöty H, Vesikari T.

Microbes Infect. 2016 Apr;18(4):263-9. doi: 10.1016/j.micinf.2015.12.004. Epub 2015 Dec 25.

27.

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine.

Blazevic V, Malm M, Arinobu D, Lappalainen S, Vesikari T.

Hum Vaccin Immunother. 2016 Mar 3;12(3):740-8. doi: 10.1080/21645515.2015.1099772.

28.

Multiple consecutive norovirus infections in the first 2 years of life.

Blazevic V, Malm M, Salminen M, Oikarinen S, Hyöty H, Veijola R, Vesikari T.

Eur J Pediatr. 2015 Dec;174(12):1679-83. doi: 10.1007/s00431-015-2591-8. Epub 2015 Jul 9.

29.

Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors.

Andersson KG, Rosestedt M, Varasteh Z, Malm M, Sandström M, Tolmachev V, Löfblom J, Ståhl S, Orlova A.

Oncol Rep. 2015 Aug;34(2):1042-8. doi: 10.3892/or.2015.4046. Epub 2015 Jun 9.

PMID:
26059265
30.

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.

Lappalainen S, Pastor AR, Malm M, López-Guerrero V, Esquivel-Guadarrama F, Palomares LA, Vesikari T, Blazevic V.

Arch Virol. 2015 Aug;160(8):2075-8. doi: 10.1007/s00705-015-2461-8. Epub 2015 May 29.

31.

Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.

Blazevic V, Malm M, Vesikari T.

J Med Virol. 2015 Oct;87(10):1656-61. doi: 10.1002/jmv.24237. Epub 2015 May 6.

PMID:
25946711
32.

Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.

Malm M, Tamminen K, Lappalainen S, Uusi-Kerttula H, Vesikari T, Blazevic V.

Clin Vaccine Immunol. 2015 Jun;22(6):656-63. doi: 10.1128/CVI.00015-15. Epub 2015 Apr 22.

33.

Women's experiences of two different self-assessment methods for monitoring fetal movements in full-term pregnancy--a crossover trial.

Malm MC, Rådestad I, Rubertsson C, Hildingsson I, Lindgren H.

BMC Pregnancy Childbirth. 2014 Oct 7;14:349. doi: 10.1186/1471-2393-14-349.

34.

High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.

Malm M, Uusi-Kerttula H, Vesikari T, Blazevic V.

J Infect Dis. 2014 Dec 1;210(11):1755-62. doi: 10.1093/infdis/jiu361. Epub 2014 Jun 26.

PMID:
24970849
35.

Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.

Malm M, Bass T, Gudmundsdotter L, Lord M, Frejd FY, Ståhl S, Löfblom J.

Biotechnol J. 2014 Sep;9(9):1215-22. doi: 10.1002/biot.201400009. Epub 2014 Apr 23.

PMID:
24678002
36.

Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays.

Uusi-Kerttula H, Tamminen K, Malm M, Vesikari T, Blazevic V.

Microbes Infect. 2014 Jun;16(6):472-80. doi: 10.1016/j.micinf.2014.02.010. Epub 2014 Mar 14.

PMID:
24631874
37.

Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule.

Orlova A, Malm M, Rosestedt M, Varasteh Z, Andersson K, Selvaraju RK, Altai M, Honarvar H, Strand J, Ståhl S, Tolmachev V, Löfblom J.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1450-9. doi: 10.1007/s00259-014-2733-7. Epub 2014 Mar 13.

PMID:
24622956
38.

Development of a tool to evaluate fetal movements in full-term pregnancy.

Malm MC, Lindgren H, Rubertsson C, Hildingsson I, Rådestad I.

Sex Reprod Healthc. 2014 Mar;5(1):31-5. doi: 10.1016/j.srhc.2013.11.003. Epub 2013 Dec 7.

PMID:
24472387
39.

Being alone in silence - mothers' experiences upon confirmation of their baby's death in utero.

Rådestad I, Malm MC, Lindgren H, Pettersson K, Larsson LL.

Midwifery. 2014 Mar;30(3):e91-5. doi: 10.1016/j.midw.2013.10.021. Epub 2013 Oct 30.

PMID:
24290197
40.

Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture.

Awong G, Singh J, Mohtashami M, Malm M, La Motte-Mohs RN, Benveniste PM, Serra P, Herer E, van den Brink MR, Zúñiga-Pflücker JC.

Blood. 2013 Dec 19;122(26):4210-9. doi: 10.1182/blood-2012-12-472803. Epub 2013 Nov 8.

41.

Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification.

Malm M, Kronqvist N, Lindberg H, Gudmundsdotter L, Bass T, Frejd FY, Höidén-Guthenberg I, Varasteh Z, Orlova A, Tolmachev V, Ståhl S, Löfblom J.

PLoS One. 2013 May 10;8(5):e62791. doi: 10.1371/journal.pone.0062791. Print 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/0d29f87c-8dfb-4694-abc7-7284a970910d.

42.

You don't leave your baby--mother's experiences after a stillbirth.

Lindgren H, Malm MC, Rådestad I.

Omega (Westport). 2013-2014;68(4):337-46.

PMID:
24968620
43.

Cellular effects of HER3-specific affibody molecules.

Göstring L, Malm M, Höidén-Guthenberg I, Frejd FY, Ståhl S, Löfblom J, Gedda L.

PLoS One. 2012;7(6):e40023. doi: 10.1371/journal.pone.0040023. Epub 2012 Jun 29.

44.

Mothers' experiences of the time after the diagnosis of an intrauterine death until the induction of the delivery: a qualitative Internet-based study.

Erlandsson K, Lindgren H, Malm MC, Davidsson-Bremborg A, Rådestad I.

J Obstet Gynaecol Res. 2011 Nov;37(11):1677-84. doi: 10.1111/j.1447-0756.2011.01603.x. Epub 2011 Jul 27.

PMID:
21793995
45.

Immunization with dendritic cells transfected in vivo with HIV-1 plasmid DNA induces HIV-1-specific immune responses.

Malm M, Krohn K, Blazevic V.

Arch Virol. 2011 Sep;156(9):1607-10. doi: 10.1007/s00705-011-1003-2. Epub 2011 Apr 28.

PMID:
21526430
46.

Waiting in no-man's-land - mothers' experiences before the induction of labour after their baby has died in utero.

Malm MC, Rådestad I, Erlandsson K, Lindgren H.

Sex Reprod Healthc. 2011 Apr;2(2):51-5. doi: 10.1016/j.srhc.2011.02.002. Epub 2011 Feb 24.

PMID:
21439521
47.

Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.

Kronqvist N, Malm M, Göstring L, Gunneriusson E, Nilsson M, Höidén Guthenberg I, Gedda L, Frejd FY, Ståhl S, Löfblom J.

Protein Eng Des Sel. 2011 Apr;24(4):385-96. doi: 10.1093/protein/gzq118. Epub 2010 Dec 21.

PMID:
21177282
48.

Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies.

Kronqvist N, Malm M, Rockberg J, Hjelm B, Uhlén M, Ståhl S, Löfblom J.

Recent Pat Biotechnol. 2010 Nov;4(3):171-82. Review.

PMID:
21171954
49.

Losing contact with one's unborn baby--mothers' experiences prior to receiving news that their baby has died in utero.

Malm MC, Lindgren H, Rådestad I.

Omega (Westport). 2010-2011;62(4):353-67.

PMID:
21661539
50.

Determination of lamivudine, zidovudine, and nevirapine in capillary blood sampled on filter paper by LC.

Malm M, Römsing S, Obua C, Bergqvist Y.

J Chromatogr Sci. 2009 Nov-Dec;47(10):855-62.

PMID:
19930794

Supplemental Content

Support Center